In this episode, Sheila Arquette, President & CEO of NASP, speaks with Marina Carter, PharmD, BCACP, Ambulatory Clinical Pharmacy Specialist with Carilion Clinic Cardiology Heart Failure Clinic and Dejan Landup, PharmD, HF-Cert, Heart Failure and Cardiovascular Clinical Pharmacist with Advocate Medical Group Heart Failure and Chronic Disease Management Clinic. Marina and Dejan share their experience identifying patients with transthyretin amyloid cardiomyopathy (ATTR‑CM). They explore the expanding role of clinical pharmacists in patient identification, collaboration with multidisciplinary care teams, and the use of tools such as the EHR to support proactive care. The conversation highlights key clinical considerations, common challenges, and the rewards of helping identify patients earlier in their care journey, while offering practical insights for pharmacists interested in becoming more involved in ATTR‑CM identification. This episode is brought to you in partnership with Pfizer.
